Drug intelligence / Profile preview

Oxyplastine 46% zinc oxide ointment

Development stage
Unknown
Lead developer
Eumedica
Modality
Small Molecules, Drug Delivery Systems
Administration
Topical
01

Overview

Oxyplastine 46% zinc oxide ointment is an over-the-counter topical skin protectant containing a high concentration of zinc oxide in an ointment base with excipients such as castor oil, lanolin, calcium hydroxide, beeswax, and perfume.[1][4][9][15] It is primarily indicated for prevention and treatment of skin irritation and inflammation, especially diaper (nappy) rash in infants, and is also used for minor skin injuries and for protecting peristomal or macerated skin exposed to moisture.[1][3][4][9][15] The high zinc oxide content forms an occlusive, absorbent barrier that shields the skin from wetness and irritants, provides mild astringent and antiseptic effects, reduces inflammation, and promotes healing of superficial lesions.[1][3][5][6][11] The lanolin- and oil-based vehicle confers strong adherence and emollient properties, enhancing barrier function and maintaining skin hydration while the product remains preservative- and colorant-free in common European formulations.[1][3][4]

Brand names
OxyplastineOxyplastine 46%
Other names
Oxyplastine NFOxyplastine zinc oxide ointment

Beyond the preview

Go deeper on Oxyplastine 46% zinc oxide ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxyplastine 46% zinc oxide ointment.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call